Company news

Imugene Ltd news in 2018

Imugene Ltd's news releases, calls and decks from 2018, newest first.

View company

IMU Meets Endpoints in Phase 1b Gastric Cancer Trial

December 16, 2018

Imugene Advances to Phase 2 in Gastric Cancer Trial

November 12, 2018

Imugene Receives $1.85 million R&D Tax Incentive

November 8, 2018

Imugene commences cGMP manufacture of PD-1 cancer vaccine

September 20, 2018

Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment

September 10, 2018

Appendix 4E and Audited Financial Report

August 31, 2018

PD-1 cancer vaccine development update

July 22, 2018

Imugene raises $20.1 million

June 7, 2018

Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio

June 6, 2018

Leslie Chong Appointed as Managing Director

March 27, 2018

Arginine Modulator Active in Cancer Models

February 18, 2018

Novel Anti-PD-1 Mimotope Vaccine Ready for Development

February 11, 2018

IMU Meets Investigator for Gastric Cancer Clinical Trial

February 8, 2018

Cancer vaccine shows early promise in clinical trial

February 6, 2018

Business Update - December Quarter Appendix 4C

January 28, 2018

Decks in 2018